Agilon Health Inc is a healthcare company that focuses on transforming the delivery of primary care through its innovative platform designed for value-based care. By partnering with primary care physicians, Agilon enhances their capabilities and support systems, allowing them to improve patient care and outcomes while managing costs more effectively. The company leverages data analytics and technology to enable a seamless integration of services, facilitating better health management for patients and creating a sustainable model for healthcare providers. Through its collaborations, Agilon is dedicated to creating a more efficient healthcare experience that prioritizes wellness and preventive care. Read More
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSE:AGL), Albany International Corporation (NYSE:AIN), Collective Mining Ltd. (NYSE:CNL), and PubMatic, Inc. (NASDAQ:PUBM). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Shares of healthcare services company Agilon Health (NYSE:AGL) fell 4.4% in the afternoon session after the company was downgraded by analysts at Bernstein from “Outperform” to “Market Perform”. The firm also slashed its price target on the stock by 65% to $1.40 from $4.00. Analyst Lance Wilkes cited “worse-than-expected margin pressures” following a disappointing quarter where the company's medical margin was a negative $53 million. This was primarily driven by lower-than-expected risk adjustment revenue for 2024 and 2025. Bernstein expressed concerns about agilon's reduced capital, which increases its cost of capital, and noted cash flow uncertainty after the company withdrew its fiscal year 2025 guidance.
Shares of healthcare services company Agilon Health (NYSE:AGL) jumped 8.1% in the morning session after the stock extended its positive momentum as it bounced back from a significant dip. The rally follows a difficult period for the company, which saw its stock plunge over 50% after the CEO stepped down and full-year 2025 financial guidance was withdrawn on August 4. The move appears to have a technical component, as the stock gained for four consecutive days.
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth-oriented sectors like healthcare, as they reduce the cost of borrowing for research and innovation and increase the present value of future earnings.
Healthcare services company Agilon Health (NYSE:AGL) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 5.9% year on year to $1.39 billion. Its non-GAAP loss of $0.25 per share was significantly below analysts’ consensus estimates.
A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare.
Rock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential.
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Shares of healthcare services company Agilon Health (NYSE:AGL) fell 51.6% in the morning session after the company reported dismal second-quarter financial results, announced the departure of its CEO, and withdrew its full-year guidance.
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
